PapersPMID:25474484
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
- findings
- 4
- compound
- 1
- endpoints
- 4
No finding here moved its endpoint.
What did not
How to read these marks →- No detected effect on diastolic blood pressure
very limited
“For diastolic blood pressure we performed a random-effects meta-analysis, which showed no evidence of effect of CoQ10 supplementation when these two small trials were pooled (MD -1.62 mmHg, 95% CI -5.2 to 1.96).”
- Study
- meta-analysis
- Effect
- −1.62 mean difference, 95% CI −5.2 to 1.96
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; pooled analysis of two small RCTs
“The trial showed no evidence of effect of CoQ10 supplementation on total cholesterol (MD 0.30 mmol/L, 95% CI -0.10 to 0.70), high-density lipoprotein (HDL)-cholesterol (MD 0.02 mmol/L, 95% CI -0.13 to 0.17) or triglycerides (MD 0.05 mmol/L, 95% CI -0.42 to 0.52).”
- No detected effect on total cholesterol (TC)
very limitedreplicated ×2
- Study
- RCT
- Effect
- 0.3 mean difference, 95% CI −0.1 to 0.7
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
- No detected effect on HDL cholesterol
very limitedreplicated ×3
- Study
- RCT
- Effect
- 0.02 mean difference, 95% CI −0.13 to 0.17
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
- No detected effect on triglycerides
very limitedreplicated ×2
- Study
- RCT
- Effect
- 0.05 mean difference, 95% CI −0.42 to 0.52
- Population
- adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- healthy adults or those at high cardiovascular risk without a diagnosis of CVD; 6 RCTs, 218 participants total
- Participants
- 218
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 9